International debate about human genome editing governance has undergone a paradigm shift and suggests that inclusive public deliberation is still important.
AMA J Ethics. 2019; 21(12):E1065-1070. doi:
10.1001/amajethics.2019.1065.
Physicians, committees, and guardians all make decisions for unrepresented patients in the US. This article considers a “tiered” approach as an alternative.
AMA J Ethics. 2019; 21(7):E587-593. doi:
10.1001/amajethics.2019.587.
When patients are unable to express their wishes and do not have surrogates or advance directives, which and whose values should inform decision making for them? We discuss ethical complexities of caring for unrepresented patients.
Shailendra Prasad, MBBS, MPH, Fatima Alwan, MS, Jessica Evert, MD, Tricia Todd, MPH, and Fred Lenhoff, MA
Short-term experiences in global health are common ways trainees engage in global health activities. Professional societies take active roles in addressing these ethical challenges.
AMA J Ethics. 2019; 21(9):E742-748. doi:
10.1001/amajethics.2019.742.